In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
about
Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugsNanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsRight or left: the role of nanoparticles in pulmonary diseasesControlled Drug Release from Pharmaceutical NanocarriersCombined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysisAdding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug-resistant tumors significantlyClinical Translation of Nanomedicine.Stereocomplexed poly(lactic acid)-poly(ethylene glycol) nanoparticles with dual-emissive boron dyes for tumor accumulation.Imaging and drug delivery using theranostic nanoparticlesUltrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsionsPolymeric micelles in anticancer therapy: targeting, imaging and triggered release.Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity.Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016).Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancerSmall-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer modelNanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.A novel size-tunable nanocarrier system for targeted anticancer drug delivery.Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis.Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.EFFECTS OF POLYMERIC NANOPARTICLE SURFACE PROPERTIES ON INTERACTION WITH BRAIN TUMOR ENVIRONMENT.Scope of nanotechnology in ovarian cancer therapeutics.Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.Comparative studies of poly(ε-caprolactone) and poly(D,L-lactide) as core materials of polymeric micelles.Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticlesNovel formulations of taxanes: a review. Old wine in a new bottle?Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting.Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug deliveryMultifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian CancerCremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature.In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticlesA pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles.Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micellesComplete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles."OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapyModification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.
P2860
Q26849241-8D96D1F5-B22E-4DAC-8A79-8D087457F589Q26860760-6E9AEE10-5EF4-4080-B115-0A8598EF4437Q27023304-A532C092-CCC1-4A47-8B6C-48F0AB55B254Q28257050-520CD303-A55E-4AD1-BD29-21EBAB5EE06DQ28487747-B555E8DF-5CD3-42EF-B268-CBC402049FF9Q28545246-DDB5CDEB-B47A-4C0A-845E-4E55FB7A5397Q30355939-4103573D-C445-4234-8411-048F1CD168C7Q30430620-1C0A68C9-4C5D-4CF8-B7AB-C8E9DF0AE4A8Q30449480-D5E626C5-B121-4EB9-8B35-D4950D8ADFDCQ30465710-E73C96FB-BA2E-4B0D-B39D-83183404BD8EQ30478123-0F57F64B-D28F-4ED0-B600-93101390AC30Q30478959-C65675E9-6CD0-4971-ACDE-C4DD46F0D21DQ30618973-D87FFB07-1032-439A-ADB8-BB4DF0AAA9B6Q33437949-CB1908EB-F90F-4985-A3FE-779E15CF4769Q33563915-A5BA227F-031D-446E-9FDE-8066624F7378Q33621256-D776BA40-471E-4D61-9CAB-D981B18717A6Q33622043-9F4A3956-F19E-447E-904E-CBBBBEE75F7FQ33864915-3B048D94-3A48-40CE-BB75-0D8431883EA7Q33886700-ED749649-13B1-4FF0-AF8E-93F1A8517707Q33902814-8499183F-03A6-4FF0-9388-B85735E28FA9Q33929284-C1183ED9-BAEF-4711-8E19-F6BC0BB99539Q34019320-5DE8C6D8-58BF-4280-A5B2-B725BCE80906Q34075216-24380D20-0A1E-4DCA-93FB-F38F53D49DA9Q34316088-15541BF8-6412-49A2-9A43-CC582C8F5886Q34488571-D3A75315-5E83-417D-A1BA-D3AE0E5BBF67Q34513963-0F11B849-20EE-4111-9B08-EE091DDF9D81Q34563540-5C132A33-A65C-4A3F-B3E7-FC5D801D59EBQ34590348-AAF28AAE-9647-4E56-8D9D-9D656402C646Q35108788-4EE5412E-0204-4DCB-84F0-75F9489428E1Q35168687-9FF829B5-B44B-4BD4-AC5F-11D8E64C9E1AQ35374920-4EEF4729-EBCE-4FF1-9002-5A951BA994F9Q35574188-7E7EEC9C-B28A-4B56-A5B5-D407DC97FEF6Q35585791-5847A658-36B1-4299-BCF3-C54CB838FEC5Q35617669-107E6124-BA17-46D2-B9A4-B3C63D007D35Q35694291-06C07AE0-A278-433F-876E-A6EFFB6DC4DFQ35911710-346B54A3-EE16-4A22-945F-2F50BDFF8867Q35932503-26D57813-7CFE-4FC7-A9D5-E5DA9DBE6D22Q35972736-ECEBB3CF-D650-498F-A80C-5A1B8DB41294Q36010319-A291ABC8-0DE3-4B42-8C40-4CAEBA0CED81Q36111924-5A04AE0D-32A1-4847-8D1A-5E16562A1170
P2860
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
@en
type
label
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
@en
prefLabel
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
@en
P2093
P1476
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy.
@en
P2093
P304
P356
10.1016/S0168-3659(01)00275-9
P407
P577
2001-05-01T00:00:00Z